Alterity Therapeutics Ltd.
No trades
No trades
Price target
1.750.000.00%
The 5 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of ATH is 0.575 AUD — it has increased by 2.73% in the past 24 hours. Watch Alterity Therapeutics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Alterity Therapeutics Ltd. stocks are traded under the ticker ATH.
ATH stock has fallen by −5.83% compared to the previous week, the month change is a −5.83% fall, over the last year Alterity Therapeutics Ltd. has showed a −17.86% decrease.
We've gathered analysts' opinions on Alterity Therapeutics Ltd. future price: according to them, ATH price has a max estimate of 3.61 AUD and a min estimate of 0.95 AUD. Watch ATH chart and read a more detailed Alterity Therapeutics Ltd. stock forecast: see what analysts think of Alterity Therapeutics Ltd. and suggest that you do with its stocks.
ATH stock is 2.61% volatile and has beta coefficient of 1.51. Track Alterity Therapeutics Ltd. stock price on the chart and check out the list of the most volatile stocks — is Alterity Therapeutics Ltd. there?
Today Alterity Therapeutics Ltd. has the market capitalization of 119.70 M, it has decreased by −7.09% over the last week.
Yes, you can track Alterity Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.
Alterity Therapeutics Ltd. is going to release the next earnings report on Aug 28, 2026. Keep track of upcoming events with our Earnings Calendar.
ATH earnings for the last half-year are −0.04 AUD per share, whereas the estimation was −0.03 AUD, resulting in a −56.52% surprise. The estimated earnings for the next half-year are −0.02 AUD per share. See more details about Alterity Therapeutics Ltd. earnings.
Alterity Therapeutics Ltd. revenue for the last half-year amounts to 909.75 K AUD, despite the estimated figure of 1.51 M AUD. In the next half-year revenue is expected to reach 3.48 M AUD.
ATH net income for the last half-year is −9.62 M AUD, while the previous report showed −4.97 M AUD of net income which accounts for 0.00% change. Track more Alterity Therapeutics Ltd. financial stats to get the full picture.
No, ATH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 23, 2026, the company has 9 employees. See our rating of the largest employees — is Alterity Therapeutics Ltd. on this list?
Like other stocks, ATH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alterity Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alterity Therapeutics Ltd. technincal analysis shows the neutral today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alterity Therapeutics Ltd. stock shows the buy signal. See more of Alterity Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.